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Receptor regulation of osmolyte homeostasis
in neural cells
Stephen K. Fisher1,2, Anne M. Heacock1, Richard F. Keep3 and Daniel J. Foster2
1Molecular and Behavioral Neuroscience Institute and 2Departments of Pharmacology, 3Neurosurgery and Molecular and Integrative Physiology,
University of Michigan, Ann Arbor, MI, USA
The capacity of cells to correct their volume in response to hyposmotic stress via the efflux
of inorganic and organic osmolytes is well documented. However, the ability of cell-surface
receptors, in particular G-protein-coupled receptors (GPCRs), to regulate this homeostatic
mechanism has received much less attention. Mechanisms that underlie the regulation of
cell volume are of particular importance to cells in the central nervous system because of
the physical restrictions of the skull and the adverse impact that even small increases in cell
volume can have on their function. Increases in brain volume are seen in hyponatraemia,
which can arise from a variety of aetiologies and is the most frequently diagnosed electrolyte
disorder in clinical practice. In this review we summarize recent evidence that the activation
of GPCRs facilitates the volume-dependent efflux of osmolytes from neural cells and permits
them to more efficiently respond to small, physiologically relevant, reductions in osmolarity.
The characteristics of receptor-regulated osmolyte efflux, the signalling pathways involved and
the physiological significance of receptor activation are discussed. In addition, we propose that
GPCRs may also regulate the re-uptake of osmolytes into neural cells, but that the influx of
organic and inorganic osmolytes is differentially regulated. The ability of neural cells to closely
regulate osmolyte homeostasis through receptor-mediated alterations in both efflux and influx
mechanisms may explain, in part at least, why the brain selectively retains its complement of
inorganic osmolytes during chronic hyponatraemia, whereas its organic osmolytes are depleted.
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Maintenance of cell volume is an ancient homeostatic
mechanism necessary for the survival and proper function
of the vast majority of cells. Alterations in cell volume can
lead to a number of changes in cell function including
excitability, cell-cycle progression, proliferation, apoptosis
and metabolic regulation (Okada et al. 2009). However,
regulation of cell volume is of particular significance to
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the central nervous system (CNS) because of the physical
restrictions of the skull. Even small changes in brain cell
volume can profoundly influence the spatial relationships
between neurons, astrocytes and the extracellular space. A
reduction in the latter, as occurs during brain cell swelling,
will result in both an increased lateral diffusion and higher
extracellular concentrations of neurotransmitters (Sykova,
2004; Thorne & Nicholson, 2006). Larger increases in
brain cell volume can compress blood vessels leading
to episodes of anoxia and ischaemia, and ultimately to
a displacement of the brain parenchyma through the
foramen magnum, leading to cardiac and respiratory
arrest (Pasantes-Morales et al. 2002).
Brain cells can swell either as a result of changes in
intracellular ion and water distribution (isotonic swelling,
as occurs in stroke or traumatic head injury) or by a
reduction in plasma osmolarity (hyposmotic swelling).
The most common cause of hyposmotic swelling is hypo-
natraemia, which is defined as reduction in serum Na+
concentration from a normal value of 145 mequiv l−1
to 136 or below. Hyponatraemia is the most frequently
encountered electrolyte disorder in clinical practice and
can arise from a diverse array of aetiologies including
congestive heart failure, syndrome of inappropriate
secretion of vasopressin, liver cirrhosis, psychotic poly-
dipsia or over-hydration, as may occur in athletes and
military personnel (Bhardwaj, 2006; Lien & Shapiro,
2007). Although patients with mild hyponatraemia are
often asymptomatic, reductions in plasma osmolarity
of >10% can elicit symptoms of nausea and headache
whereas seizures, coma, permanent brain damage and
death can occur when plasma osmolarity is chronically
reduced by >20%. The focus of this review is on the end-
ogenous molecular mechanisms that restore brain volume
when neural cells are subjected to hyposmotic stress.
In particular, the emergence of a potentially important
physiological role for cell surface receptors in this process,
in both the efflux and re-uptake of osmolytes, is discussed.
Mechanisms for restoration of neural cell volume
During episodes of hyponatraemia, the reduction in
plasma osmolarity results in an influx of water into
the brain through the blood–brain barrier and into
neural cells across their plasma membranes. However, the
increases in brain water are less than expected from a
perfect osmometer (Verbalis & Drutarosky, 1988). This
reflects the presence of two homeostatic mechanisms
that reduce the potential impact of water influx. The
first is an increase in the flow of fluid from the inter-
stitial space into the cerebrospinal fluid and from there
to the systemic circulation. This phase accounts for the
rapid loss of Na+ and Cl− ions from brain observed
at the onset of hyponatraemia. The second, and more
sustained mechanism, is an efflux of osmotically active
solutes from the cells, primarily inorganic ions such as
K+ and Cl− and small organic molecules, such as taurine,
glutamate or myo-inositol. This in turn leads to the exit of
osmotically obligated water and reduces cellular swelling.
The mechanism whereby the increase in cell volume is
detected by a hypothetical ‘volume sensor’, and the signal
transduction events that elicit volume correction, remain
largely unknown, with the exception that a tyrosine kinase
has frequently been implicated.
Although organic osmolytes potentially contribute
less than their inorganic counterparts to cell volume
adaptation (35 and 65%, respectively), organic osmolytes
are highly enriched in the CNS and their utilization mini-
mizes changes in membrane potential associated with
the efflux of inorganic osmolytes such as K+ or Cl−.
However, it should be remembered that several of the
quantitatively major organic osmolytes are ‘neuroactive’
and can activate their respective receptors on nearby
neurons and glia. Thus, as discussed later, their release
under conditions of volume correction is not without
neurobiological consequences. The normalization of cell
volume that occurs as a result of osmolyte loss is referred to
as regulatory volume decrease (RVD). Volume-dependent
osmolyte efflux is mediated via a variety of anion/cation
channels, including K+ channels (both Ca2+-dependent
and -independent), the K+–Cl− co-transporter (KCC)
and a putative volume-sensitive organic osmolyte and
anion channel (VSOAC; Fig. 1). The latter is yet to
be characterized at a molecular level, but is thought
to be primarily a swelling-activated Cl− channel that
also mediates the efflux of organic osmolytes (Okada,
2006; Kimelberg et al. 2006). Swelling-activated efflux
of osmolytes has been monitored in a variety of neural
preparations including primary cultures of neurons
and astrocytes, neurotumour cell lines, nerve-ending
preparations and brain slices (for review, see Fisher et al.
2008).
A role for cell-surface receptors in the regulation
of volume-sensitive osmolyte efflux
Although volume regulation has previously been
considered to be an intrinsic property of cells, it is
now evident that many extracellular agonists, acting
via cell-surface receptors, can profoundly influence this
process (for reviews see Fisher et al. 2008; Franco et al.
2008; Vasquez-Juarez et al. 2008). An indication that
GPCRs could potentially be involved in osmoregulation
in neural cells was obtained from experiments in which
agents that mimic the activation of certain categories
of cell-surface receptors, for example by increasing the
concentration of cytosolic Ca2+ or activities of protein
kinase C (PKC) or protein kinase A (PKA), were observed
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to potentiate volume-dependent osmolyte release from
cells. However, Bender et al. (1993) provided the first direct
demonstration of the involvement of G-protein-coupled
receptors (GPCRs) in volume control when they reported
that RVD in cultured astrocytes exposed to hypotonic
media was accelerated by the addition of endothelin
or noradrenaline (norepinephrine). However, only in
the last few years has the potential contribution of
cell-surface receptors to the regulation of osmolyte fluxes
in the CNS been systematically examined. A significant
number of pharmacologically distinct receptors have now
been identified to regulate osmolyte fluxes and volume
control in a variety of different neural preparations
(for summary, see Table 1). Although a diverse array
of receptors has been identified, a number of common
characteristics are apparent. First, with some exceptions
(e.g. AMPA, vascular endothelial growth factor and
erythropoeitin receptors), most documented examples of
receptor regulation of osmolyte fluxes and/or volume
control involve the activation of GPCRs and, where
examined, the effects are mediated via pharmacologically
distinct receptor subtypes. Under hyposmotic conditions,
receptor activation almost invariably leads to a facilitation
of osmolyte efflux and, when monitored, an enhancement
of RVD (see Ramos-Mandujano et al. 2007). However,
it remains possible that a category of GPCRs may also
serve to negatively regulate osmolyte efflux and volume
correction, as has been observed for the adenosine
A2B receptor in pituicytes (Pierson et al. 2007). The
GPCRs coupled to an increase in osmolyte efflux typically
respond to neurotransmitters or neuromodulators (e.g.
neuropeptides, cholinergic or adrenergic agonists, ATP,
thrombin or lysophospholipids) at nanmolar or micro-
molar concentrations, i.e. well within the concentration
range found in vivo.
A second characteristic of receptor-stimulated
osmolyte efflux is that the release of organic osmolytes
and Cl− can be blocked by inclusion of known
inhibitors of VSOAC, such as DCPIB (4-[(2-butyly-6,7-
dichloro-2-cyclopentenyl-2,3-dihydo-1-oxo-1H-inden-5-
yl)oxy] butanoic acid), DDF (1,9-dideoxyforskolin) or
NPPB, (4,4′-diisothiocyanatostilbene-2,2′-disulphonic
acid). This is the same pharmacological profile as is
observed under basal (swelling-activated) conditions
and indicates that the same or similar channels mediate
osmolyte release under both conditions. A third
characteristic is that osmolyte efflux is only significantly
increased following receptor activation under hyposmotic
conditions, whereas little or no increase is observed
under isotonic or hypertonic conditions (see Fig. 2A).
From this observation it can be concluded that GPCRs
serve to regulate, rather than initiate, the activity of
channels that are involved in osmolyte release. Fourth,
as initially described by Mongin & Kimelberg (2002)
for ATP-stimulated release of D-aspartate from primary
cultures of astrocytes, receptor activation appears to
lower the threshold osmolarity at which osmolyte release
occurs. An additional example of this phenomenon is
shown in Fig. 2 for human SH-SY5Y neuroblastoma
cells, a model neuronal cell line. For these cells, no
measurable increase in the basal (swelling-activated)
release of either taurine or Rb+ (used as a marker for
K+) over that monitored under isotonic conditions
is observed until the osmolarity of the medium is
reduced by ∼30%. Similar large, non-physiologically
relevant, reductions in osmolarity have frequently been
required to reliably monitor osmolyte efflux from other
neural preparations under basal conditions. In contrast,
the activation of muscarinic cholinergic receptors
(mAChRs) on SH-SY5Y cells permits the release of
Figure 1. General schematic representation of events leading to
swelling-activated (basal)- and GPCR-mediated osmolyte efflux
A reduction in osmolarity results in an influx of water and an increase
in cell volume, which in turn triggers a hypothetical ‘volume sensor’. It
has been proposed that the latter may represent changes in
macromolecular crowding and/or changes in the cytoskeleton.
Activation of the volume sensor elicits a tyrosine kinase
(TK)-dependent activation of K+ channels (both Ca2+-dependent and
-independent), VSOAC and, on occasions, the KCC transporter. This
results in the efflux of K+, Cl−, organic osmolytes and osmotically
obligated water. The latter results in a restoration of cell volume or
‘regulatory volume decrease’. Volume-dependent efflux of inorganic
and organic osmolytes can also be significantly increased by activation
of GPCRs, the magnitude of which is often dependent on Ca2+
availability and PKC activity. Note that GPCR activation of osmolyte
release is strongly dependent on prior activation of the volume sensor
and little or no increase is seen under isotonic or hypertonic conditions.
Pharmacological evidence indicates that the same or similar channels
mediate osmolyte efflux under basal- and GPCR-stimulated conditions.
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Table 1. Receptor-mediated regulation of osmolyte fluxes or cell volume under hyposmotic conditions
Receptor Subtype Signalling pathways Cell type Parameter Reference
Adenosine A1 PKA Retina Cell volume Uckermann et al. 2006
A1 PKA/PI3K/Akt Retina Cell volume Wurm et al. 2008
A2B PKA Pituicytes Taurine flux Pierson et al. 2007
Purinergic P2Y ND Retina Cell volume Uckermann et al. 2006;
Wurm et al. 2008
P2Y Ca2+/PKC/CaM/CaMKII Cortical astrocytes D-Asp flux Mongin & Kimelberg,
2002, 2005
P2Y ND Cortical astrocytes D-Asp/Cl− flux Abdullaev et al. 2006
P2Y ND Cortical astrocytes Cl− flux Darby et al. 2003
ND Ca2+ Pituicytes Taurine flux Rosso et al. 2004
ND ND Hippocampal neurons Taurine/Cl− flux Li & Olson, 2004
ND ND Substantia nigra Taurine flux Morales et al. 2007
Bradykinin ND Ca2+ Pituicytes Taurine flux Rosso et al. 2004
Endothelin ND PPI hydrolysis Cortical astrocytes Cell volume Bender et al. 1993
Erythropoietin ND Jak-2/ERK1/2 Retina Cell volume Krugel et al. 2010
Glutamate AMPA ND Substantia nigra Taurine flux Morales et al. 2007
mGluR ND Retina Cell volume Uckermann et al. 2006;
Wurm et al. 2008
LPA ND Ca2+/PKC SH-SY5Y Taurine flux Heacock et al. 2006
ND ND SH-SY5Y K+ flux Foster et al. 2008
NA ND PPI hydrolysis Cortical astrocytes Cell volume Bender et al. 1993
β-AR PKA Cortical astrocytes Taurine flux Moran et al. 2001
mAChR M3 PKC/Ca2+/Tyr kinases SH-SY5Y D-Asp/taurine flux Heacock et al. 2004
M3 Ca2+/PKC SH-SY5Y Inositol flux Loveday et al. 2003
M3 Ca2+/PKC SH-SY5Y Cl− flux Cheema et al. 2007
M3 Ca2+/PKC SH-SY5Y K+ flux Foster et al. 2008
S1P ND Ca2+/PKC SH-SY5Y Taurine flux Heacock et al. 2006
ND ND SH-SY5Y K+ flux Foster et al. 2008
PAR PAR-1 ND Cortical astrocytes Taurine flux Cheema et al. 2005
PAR-1 Ca2+/PKC/CaM/PI3K Cortical astrocytes D-Asp flux Ramos-Mandujano et al.
2007
ND PPI hydrolysis Cortical astrocytes Cell volume Bender et al. 1993
PAR-1 Ca2+/PKC SH-SY5Y Taurine flux Cheema et al. 2007
PAR-1 ND SH-SY5Y Cl− flux Cheema et al. 2007
PAR-1 ND SH-SY5Y K+ flux Foster et al. 2008
PAR-1 Ca2+/PKC 1321N1 astrocytoma Taurine flux Cheema et al. 2005
PAR-1 Ca2+/Rho GTPase 1321N1 astrocytoma ATP flux Blum et al. 2010
Vasopressin V1A Ca2+ Pituicytes Taurine flux Rosso et al. 2004
V1A ND Neocortex Cell volume Niermann et al. 2001
V1A ND Cortical astrocytes Cell volume Sarfaraz & Fraser, 1999
VEGF VEGFR-2 Ca2+/PLC/PKC/src Retina Cell volume Wurm et al. 2008
Abbreviations: β-AR, β-adrenergic-receptor; D-Asp, D-aspartate; CaM, calmodulin; CaMKII, calmodulin-dependent protein kinase II;
mGluR, metabotropic glutmate receptor; NA, noradrenaline; ND, not determined; PLC, phospholipase C; PPI, phosphoinositide;
VEGF, vascular endothelial growth factor; VEGFR-2, vascular endothelial growth factor receptor 2. Jak-2, Janus kinase-2 and ERK1/2,
Extracellular signal regulated kinases 1 or 2.
osmolytes in a volume-dependent manner at relatively
modest reductions in osmolarity (>6% for taurine and
>9% for Rb+). Activation of other GPCRs present on
SH-SY5Y cells such as sphingosine 1-phosphate (S1P),
lysophosphatidic acid (LPA) and protease-activated-1
(PAR-1) receptors also reduced the threshold osmolarity
at which taurine was released (Heacock et al. 2006;
Cheema et al. 2007). The ability of GPCRs to increase
not only the magnitude of osmolyte release but also the
threshold osmolarity at which the release occurs, may
provide a physiological mechanism whereby neural cells
are able to respond to reductions in osmolarity in the
range that is encountered in hyponatraemia.
Hyposmolarity has also been reported to enhance the
release of several potential ligands for GPCRs, thereby
increasing the likelihood of their activation (Tuz et al. 2004;
Tuz & Pasantes-Morales, 2005; Blum et al. 2010). One such
ligand is ATP, which is released at an increased rate from
C© 2010 The Authors. Journal compilation C© 2010 The Physiological Society
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cells in response to hyposmotic stress (Corriden & Insel,
2010). ATP then contributes to RVD by triggering the
efflux of both inorganic and organic osmolytes, an effect
mediated via purinergic receptors. A role for ATP (and
also its breakdown product, ADP) in osmolyte homeo-
stasis has been frequently observed for primary cultures
of astrocytes and neurons, neurotumour cells and the
retina (Table 1). The importance of purinergic mediation
of volume control in the retina is indicated by the fact
that retinal glial cells do not swell in response to hyp-
osmolarity unless the P2Y receptor is pharmacologically
blocked. Thus in response to hyposmolarity, glia (and
possibly nearby neurons) are thought to release ATP,
which, in an autocrine or paracrine fashion, serves to
minimize cell swelling (Wurm et al. 2010). In contrast,
retinal glial cells obtained from P2Y knockout mice exhibit
swelling in response to hyposmolarity, but this can be
countered by administration of ATP. At least in retinal
glial cells, it appears that the final mediator of volume
correction is not ATP itself, but adenosine, derived from
the breakdown of ATP. Adenosine is proposed to facilitate
K+ and Cl− efflux via activation of adenosine A1 receptors.
Consistent with this mechanism is the observation that
volume regulation is impaired in glial cells deficient in
adenosine A1 receptors (Wurm et al. 2010). In addition to
its efflux under hyposmotic conditions, the release of ATP
can be further increased following activation of the PAR-1
receptor, mediated by thrombin (Blum et al. 2010). Since
activation of the PAR-1 receptor itself has previously been
documented to facilitate osmolyte release and volume
correction (Cheema et al. 2005; Ramos-Mandujano et al.
2007; Blum et al. 2010), it is conceivable that a release of
ATP may contribute to some of the effects on osmolyte
efflux elicited by activation of other GPCRs. However,
not all cells possess P2Y receptors (e.g. SH-SY5Y neuro-
blastoma or 1321N1 astrocytoma cells) and thus, an
obligatory role for ATP release in regulating osmolyte
efflux following GPCR activation appears unlikely.
Figure 2. Basal- and oxotremorine-M (Oxo-M)-
stimulated efflux of taurine and Rb+ as a function
of osmolarity
SH-SY5Y neuroblastoma cells, prelabelled overnight
with either [14C]taurine or 86Rb+, were incubated in
isotonic, hypertonic or hypotonic media for either
20 min (taurine) or 5 min (Rb+) in the absence (open
bars) or presence (filled bars) of 100 μM Oxo-M, a
muscarinic cholinergic agonist. Results are expressed as
taurine or Rb+ efflux (percentage of total soluble
radioactivity) and are the means ± S.E.M. for 4–13
experiments. A, taurine efflux; B, Rb+ efflux. ∗Different
from basal efflux, P < 0.05 by paired Student’s t test.
∗∗Different from basal efflux monitored under isotonic
conditions, P < 0.01 by one-way ANOVA, followed by
Dunnett’s multiple comparison test. Data are taken from
Heacock et al. (2004) and Foster et al. (2008).
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Signal transduction pathways that mediate
GPCR-mediated stimulation of osmolyte efflux
Many of the GPCRs that have thus far been identified
to facilitate osmolyte efflux are also those known to
regulate Ca2+ homeostasis and the activation of PKC.
Examples of receptors in this category are the P2Y
purinergic, M3 mAChR, PAR-1, LPA, S1P and V1A vaso-
pressin receptors. Accordingly, attenuation of the ability of
GPCRs to regulate osmolyte release or modulate volume
control is consistently observed following depletion of
intra/extracellular Ca2+ or inhibition of PKC. If intra-
cellular Ca2+ is depleted and PKC inhibited, receptor
regulation of osmolyte efflux is essentially abolished. It
should be stressed that the Ca2+- and PKC-dependence
of receptor-stimulated efflux is in marked contrast
to that observed for swelling-activated efflux, which
appears to be relatively independent of both parameters.
These observations are consistent with the proposal
that distinct up-steam mechanisms underlie basal- and
receptor-mediated osmolyte efflux, even though the
same or similar channels are used for the exit of
osmolytes from cells under both conditions (Mongin
& Kimelberg, 2005; Heacock et al. 2006). Although the
evidence for a requirement for Ca2+ in osmoregulation
is compelling, the source of this Ca2+ (extra- or intra-
cellular) appears to be both receptor- and cell-type-specific
(Cheema et al. 2005; Mongin & Kimelberg, 2005, Heacock
et al. 2006; Wurm et al. 2010). Moreover, no simple
relationship exists between the magnitude of increase in
Ca2+ concentration elicited by activation of individual
GPCRs in a specific cell type and the extent of osmolyte
release (Heacock et al. 2006). An additional complexity
is that the release of inorganic osmolytes (K+, Cl−)
appears less sensitive to the removal of Ca2+ than that
of organic osmolytes, a result that suggests that distinct
biochemical requirements may exist for the two classes
of osmolytes within the same cell (Cheema et al. 2007;
Foster et al. 2008). It is also evident that osmolyte
release can be facilitated by Ca2+-mobilizing receptors
that operate via either phospholipase C-dependent or
-independent mechanisms (Heacock et al. 2006). The
down-stream effectors for Ca2+ have yet to be identified
but may include calmodulin (Mongin & Kimelberg, 2005;
Ramos-Mandujano et al. 2007) and/or PKC. There is also
evidence for the involvement of two conventional (Ca2+-
and diacylglycerol-dependent) isoforms of PKC (α and
β) in ATP-mediated D-aspartate release from astrocytes
(Rudkouskaya et al. 2008).
Other signalling pathways have also been implicated
in receptor-mediated osmolyte efflux. These include
phosphatidylinositol 3-kinase (PI3K; Ramos-Mandujano
et al. 2007), tyrosine kinases (Heacock et al. 2004; Mongin
& Kimelberg, 2005) and protein kinase A. Evidence for
involvement of the latter pathway has been obtained
for β-adrenergic stimulation of taurine efflux from
cortical astrocytes (Moran et al. 2001) and for adenosine
A1 receptor-mediated volume changes in retinal glial
cells (Uckermann et al. 2006; Wurm et al. 2010). In
summary, it appears likely that cell volume regulation by
GPCRs involves the activation of several distinct signalling
pathways.
Is osmolyte influx an additional mechanism whereby
GPCRs can regulate osmolyte homeostasis?
When monitored under acute conditions in vitro, the
rate of efflux of inorganic osmolytes from neural cells
under both basal- and receptor-stimulated conditions
either exceeds, or is comparable to, that observed for
organic osmolytes. In contrast, chronic hyponatraemia
in vivo results in a disproportionately greater loss of
organic osmolytes than of inorganic osmolytes from the
brain (Melton et al. 1987; Pasantes-Morales et al. 2002;
Massieu et al. 2004). Similarly, if primary astrocytes are
chronically cultured in a hyposmotic medium, organic
osmolytes such as taurine or aspartate are lost from
the cells whereas K+ is retained (Olson, 1999). One
potential explanation for this discrepancy is that the
influx of inorganic and organic osmolytes, like that of
their efflux, is also volume dependent, but that the two
classes of osmolyte are differentially regulated by hyp-
osmolarity. In keeping with this possibility, previous
studies have indicated that hyposmotic swelling of
astrocytes results in a stimulation of K+ influx (Mongin
et al. 1994, 1996) whereas, in contrast, a down-regulation
of the taurine transporter (TauT) in hippocampal neurons
has been reported in response to a reduced osmolarity
(Olson & Martinho, 2006). However, whether the influx
of osmolytes, like that of their efflux, is also subject to
receptor regulation in an osmosensitive manner, remains
to be determined. In a recent series of studies, we have
systematically examined this possibility by monitoring the
influx of three distinct osmolytes, namely K+, taurine and
glutamate in SH-SY5Y neuroblastoma. Agonist occupancy
of several GPCRs (mAChR, LPA receptor, PAR-1 and S1P
receptor) in this cell line under isotonic conditions resulted
in an increase in the uptake of K+ (monitored as 86Rb+
flux) that was further enhanced when the osmolarity
was reduced (Foster et al. 2008). A similar increase
in K+ influx was also obtained following activation of
PAR-1, LPA and S1P receptors in primary cultures of
astrocytes, cells that are known to actively regulate K+
concentrations in the extracellular space. Thus activation
of GPCRs appears to facilitate both the efflux and influx
of K+ in an osmosensitive manner. However, whereas K+
channels and the KCC transporter mediate the efflux of
K+, influx occurs via the Na+–K+–2Cl− co-transporter
(NKCC), ouabain-sensitive Na+–K+-ATPase and to a
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lesser extent KCC (Fig. 3A). A physiological role for K+
uptake under hyposmotic conditions was indicated by
the observation that activation of mAChRs under either
isotonic or mildly hypotonic conditions did not result in
a change in the intracellular concentration of K+, unless
the influx of K+ was concurrently prevented by inclusion
of ouabain and furosemide (frusemide) (an inhibitor
of NKCC). This result suggests that, under normal
conditions, the agonist stimulation of K+ efflux from cells
is countered by an equivalent increase in K+ influx. Only
under more pronounced hypotonic conditions (>30%
reduction in osmolarity) were reductions in intracellular
K+ concentration observed, due to the predominance of
the efflux pathway (Foster et al. 2008).
In contrast to the results obtained for K+ influx,
activation of GPCRs in SH-SY5Y cells (mAChR, LPA, S1P
or PAR-1 receptors) results in a reduction in the rate of
taurine transport under isotonic conditions, an effect that
is further enhanced by hyposmolarity (Fig. 3B). Similar
results were obtained for primary cultures of astrocytes.
The receptor-mediated reduction in taurine transport in
SH-SY5Y cells was Ca2+ dependent and resulted from a
reduction in the V max for transport while the K m value
for taurine uptake remained unchanged (Foster et al.
2009). The loss of taurine from cells under hypotonic
conditions thus reflects not only an increased rate of
efflux through VSOAC, but also its reduced re-uptake
from the extracellular space. These observations could
explain, in part at least, the dramatic loss of taurine
observed from the brain during chronic hyponatraemia
(Massieu et al. 2004). As TauT-mediated uptake involves
the co-transport of two Na+ ions and one Cl− ion,
the inhibition of taurine re-uptake will also have the
net effect of preventing the uptake of four osmolyte
equivalents per cycle. Taurine is considered to be a
relatively inert organic osmolyte and a significant increase
in its extracellular concentration might be expected to have
only minimal cellular consequences. However, a similar
increase in the concentration of extracellular glutamate,
another quantitatively important organic osmolyte within
the CNS, would be potentially deleterious, due to the
known ability of glutamate to contribute to the rate
of propagation of spreading depression, a slow wave
of astrocytic and neuronal depolarization that leads
to synaptic depression (Basarsky et al. 1999). Higher
concentrations of extracellular glutamate can also elicit
excitotoxic death in neurons. Accordingly, blockade
of glutamate release by pharmacological inhibition of
VSOAC activity can significantly reduce the infarct size
following focal cerebral ischaemia (Zhang et al. 2008). To
Figure 3. Diagrammatic representation of the ability of GPCRs present in SH-SY5Y cells to regulate
the efflux and uptake of K+ (A), taurine (B) or glutamate (C) under isotonic (Iso) or hypotonic (Hypo)
conditions
Although only a limited efflux of osmolytes is observed following the activation of GPCRs under isotonic conditions,
the efflux of all three is markedly increased by hypotonicity (as indicated by the relative size of the arrows). The
efflux of K+ is mediated primarily by K+ channel(s) whereas taurine (Tau) and glutamate (Glu) are released via
the VSOAC. K+ uptake, which is principally mediated by Na+–K+-ATPase and the NKCC transporters in this cell
line, is facilitated by GPCR activation under conditions of isotonicity, and further enhanced by hyposmolarity. In
contrast, under isotonic conditions, GPCR activation results in an inhibition of taurine uptake, which is mediated
via the taurine transporter (TauT). This inhibition of TauT is further enhanced by hyposmolarity. Glutamate uptake,
which is mediated by EAAT3, is markedly increased by GPCR activation under isotonic conditions. However,
receptor-mediated stimulation of Glu uptake is progressively inhibited as osmolarity is reduced.
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determine whether similar or distinct mechanisms exist
for glutamate and taurine homeostasis, glutamate uptake
into SH-SY5Y cells (monitored as D-[3H]aspartate influx)
was measured as a function of osmolarity and receptor
activation. Glutamate uptake was substantially increased
under isotonic conditions by activation of mAChRs
and to a lesser extent by endothelin or LPA receptors
(Foster et al. 2010). The mAChR-mediated enhancement
of glutamate uptake, which required the presence of
Ca2+ and activation of PKC and PI3K, was mediated
by a cellular redistribution to the plasma membrane
of the excitatory amino acid transporter 3 (EAAT3), a
neuron-specific transporter. However, the ability of the
mAChR to facilitate glutamate uptake was significantly
attenuated by hyposmolarity (>45% following a 21%
reduction in osmolarity). As observed for the taurine
transporter, the osmosensitive attenuation of glutamate
uptake reflects a reduction in the V max for transport
without a change in K m and was accompanied by an altered
trafficking pattern of the transporter (Fig. 3C; Foster et al.
2010). Endothelin-1-stimulated increases in glutamate
uptake into C6 glioma cells (mediated by EAAT3) were
similarly attenuated by hyposmolarity indicating that
receptor-mediated regulation of glutamate transport may
be a general, rather than cell-specific, phenomenon.
The regulation of EAAT3-mediated glutamate uptake
could potentially have physiological consequences in
the intact brain. Thus under conditions of isotonicity
or mild hypotonicity, activation of GPCRs may permit
EAAT3-containing neurons to maintain relatively low
concentrations of extracellular glutamate. However, when
osmolarity is further reduced, a combination of glutamate
efflux, along with a progressive inhibition of glutamate
re-uptake, could result in an increased accumulation of
extracellular glutamate.
In addition to glutamate, other quantitatively major
organic osmolytes such as aspartate, glycine or GABA
are neuroactive and thus their release from osmotically
swollen cells, which is enhanced following the activation
of GPCRs, can be expected to impact nearby neurons
and glia. Even taurine, which is generally considered
to be relatively inert, can act as a ligand at glycine,
GABAA, GABAB and N-methyl-D-aspartate receptors.
Thus the ability of GPCRs to facilitate the release of
organic osmolytes constitutes a ‘double-edged sword’
in that both the beneficial effects of volume reduction
and the potentially harmful pathophysiological effects
of higher extracellular organic osmolyte concentrations
need to be considered. An ability of neural cells to
selectively retain or release individual organic osmolytes
via differential regulation of their re-uptake might
provide a mechanism whereby selectivity of organic
osmolyte release is attained. However, the full physio-
logical significance of tonicity-mediated changes in
receptor-stimulated osmolyte uptake remains to be
directly evaluated in vivo.
Summary and conclusions
Regulation of osmolyte fluxes and cell volume following
GPCR activation has been documented in both neural and
non-neural cells. However, this regulatory mechanism is
likely to be of particular physiological significance to the
CNS given the prevalence of GPCRs (∼300 identified) and
the vulnerability of the brain to osmotic disturbances. The
identification of GPCRs that not only regulate the efflux
of osmolytes, but also their re-uptake, may provide neural
cells with the ability to respond to small, physiologically
relevant, reductions in osmolarity and to selectively retain
or relinquish individual osmolytes.
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